Compare TSHA & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSHA | SPB |
|---|---|---|
| Founded | 2019 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2020 | 1994 |
| Metric | TSHA | SPB |
|---|---|---|
| Price | $6.44 | $87.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $11.63 | ★ $82.40 |
| AVG Volume (30 Days) | ★ 2.8M | 312.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | ★ 5.56 | N/A |
| EPS | N/A | ★ 1.01 |
| Revenue | $9,773,000.00 | ★ $3,802,100,000.00 |
| Revenue This Year | N/A | $2.03 |
| Revenue Next Year | $1,152.42 | $1.85 |
| P/E Ratio | ★ N/A | $41.73 |
| Revenue Growth | 17.28 | ★ 20.86 |
| 52 Week Low | $2.69 | $49.99 |
| 52 Week High | $7.30 | $99.06 |
| Indicator | TSHA | SPB |
|---|---|---|
| Relative Strength Index (RSI) | 57.92 | 48.08 |
| Support Level | $5.28 | $79.63 |
| Resistance Level | $6.76 | $90.60 |
| Average True Range (ATR) | 0.35 | 3.09 |
| MACD | 0.10 | -0.29 |
| Stochastic Oscillator | 87.50 | 8.38 |
Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, which generates maximum revenue; Global Pet Care; and Home and Garden. The company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific. It generates maximum revenue from North America.